Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-28 @ 1:06 AM
Study NCT ID:
NCT06188858
Status:
COMPLETED
Last Update Posted:
2024-01-03
First Post:
2023-12-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity Lymphedema
Sponsor:
Taizhou Hospital
Organization:
Study Overview
Official Title:
Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity
Status:
COMPLETED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our aim was to identify optimal incision sites for LVA in extremity lymphedema that would result in the most effective drainage effect for reducing limb edema and enhancing patients' quality of life.
Detailed Description:
designing the optimal incision sites and identifying functional lymphatic vessels imaging is crucial for success, primarily due to its efficacy in draining edematous lymphatic fluid and reducing swelling in patients with lymphedema. In this study, we conducted patients with LVA lymphedema to investigate the correlation between LVA incision design, intraoperative functional lymphatic vessel assessment, postoperative limb reduction, and patient satisfaction.
question 1：Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity lymphedema
question 1：Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity lymphedema
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: